Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7526)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2017 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jung JH, Lee HJ, Lee HS, Jo JH, Cho IR, Chung MJ, Park JY, Park SW, Song SY, Bang S. Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma. World J Gastroenterol 2017; 23(18): 3301-3308 [PMID: 28566890 DOI: 10.3748/wjg.v23.i18.3301] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v23/i18/3301.htm |
| Number | Citing Articles |
| 1 |
Srinivas Gaddam, Gregory A. Coté. The importance of the “endoscopic oncologist” in the treatment of nonoperable cholangiocarcinoma. Gastrointestinal Endoscopy 2020; 92(6): 1213 doi: 10.1016/j.gie.2020.06.013
|
| 2 |
Leila T. Tchelebi, Krishan R. Jethwa, Anna T. Levy, Christopher J. Anker, Timothy Kennedy, Elliot Grodstein, Christopher L. Hallemeier, Salma K. Jabbour, Ed Kim, Rachit Kumar, Percy Lee, William Small, Vonetta M. Williams, Navesh Sharma, Suzanne Russo. American Radium Society (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma. American Journal of Clinical Oncology 2023; 46(2): 73 doi: 10.1097/COC.0000000000000969
|
| 3 |
Andrea Lauterio, Riccardo De Carlis, Leonardo Centonze, Vincenzo Buscemi, Niccolò Incarbone, Ivan Vella, Luciano De Carlis. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers 2021; 13(15): 3657 doi: 10.3390/cancers13153657
|
| 4 |
Gonzalo Sapisochin, Tommy Ivanics, Vijay Subramanian, Majella Doyle, Julie K. Heimbach, Johnny C. Hong. Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: A review of the general principles. International Journal of Surgery 2020; 82: 77 doi: 10.1016/j.ijsu.2020.04.067
|
| 5 |
Zijiao Yang, Xia Jiang. Efficacy and safety comparison of neoadjuvant chemotherapy followed by surgery and upfront surgery for treating intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02754-y
|
| 6 |
Viet H. Le, Victoria V. O'Connor, Daneng Li, Laleh G. Melstrom, Yuman Fong, Andrew L. DiFronzo. Outcomes of neoadjuvant therapy for cholangiocarcinoma: A review of existing evidence assessing treatment response and R0 resection rate. Journal of Surgical Oncology 2021; 123(1): 164 doi: 10.1002/jso.26230
|
| 7 |
Jiong Lu, Bei Li, Fu-Yu Li, Hui Ye, Xian-Ze Xiong, Nan-Sheng Cheng. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?. European Journal of Surgical Oncology 2019; 45(11): 2173 doi: 10.1016/j.ejso.2019.06.014
|
| 8 |
Michail Papamichail, Michail Pizanias, Nigel D Heaton. Minimizing the risk of small-for-size syndrome after liver surgery. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 113 doi: 10.1016/j.hbpd.2021.12.005
|
| 9 |
Christian Prinz, Robin Frese, Mashiba Grams, Leonard Fehring. Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma. Genes 2022; 13(8): 1479 doi: 10.3390/genes13081479
|
| 10 |
Kazuki Terashima. Management of Pancreatic Cancer and Cholangiocarcinoma. 2021; : 157 doi: 10.1007/978-981-16-2870-2_13
|
| 11 |
Casey M. Silver, Rachel H. Joung, Charles D. Logan, Al B. Benson, Devalingam Mahalingam, Michael I. D'Angelica, David J. Bentrem, Anthony D. Yang, Karl Y. Bilimoria, Ryan P. Merkow. Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma. Journal of Surgical Oncology 2023; 127(1): 90 doi: 10.1002/jso.27112
|
| 12 |
Sinead Cremen, Michael E. Kelly, Tom K. Gallagher. The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.975136
|
| 13 |
H. Catherine Wilbur, Heloisa P. Soares, Nilofer S. Azad. Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations. Hepatology 2024; doi: 10.1097/HEP.0000000000000760
|
| 14 |
Lynn E. Nooijen, Lotte C. Franken, Ali Belkouz, Ikrame Oulad Abdennabi, Marc G. Besselink, Olivier R. Busch, Rutger-Jan Swijnenburg, Heinz-Josef Klümpen, Joris I. Erdmann. Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma. American Journal of Clinical Oncology 2021; 44(10): 526 doi: 10.1097/COC.0000000000000861
|
| 15 |
Michael Ghio, Adarsh Vijay. Intrahepatic cholangiocarcinoma: Evolving role of neoadjuvant and targeted therapy. Annals of Hepato-Biliary-Pancreatic Surgery 2023; 27(2): 123 doi: 10.14701/ahbps.22-110
|
| 16 |
Sung Hoon Choi, Incheon Kang, Sung Hwan Lee, Beodeul Kang, Jaekyung Cheon, Dae Jung Kim, Gwangil Kim, Chang-Il Kwon, Kwang Hyun Ko, Hong Jae Chon. Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinoma. Surgery 2023; 173(2): 280 doi: 10.1016/j.surg.2022.09.028
|
| 17 |
Michael J Passeri, Maria R Baimas-George, Jesse K Sulzer, David A Iannitti, John B Martinie, Erin H Baker, Lee M Ocuin, Dionisios Vrochides. Prognostic impact of the Bismuth-Corlette classification: Higher rates of local unresectability in stage IIIb hilar cholangiocarcinoma. Hepatobiliary & Pancreatic Diseases International 2020; 19(2): 157 doi: 10.1016/j.hbpd.2020.02.001
|
| 18 |
Sung Ho Lee, Gi Hong Choi, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Seoung Yoon Rho. Chronological analysis of surgical and oncological outcomes after the treatment of perihilar cholangiocarcinoma. Annals of Hepato-Biliary-Pancreatic Surgery 2021; 25(1): 62 doi: 10.14701/ahbps.2021.25.1.62
|
| 19 |
Eleni Gkika, Maria A. Hawkins, Anca-Ligia Grosu, Thomas B. Brunner. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.604387
|
| 20 |
Yutaka Suzuki, Yoshihiro Sakamoto. Management of Pancreatic Cancer and Cholangiocarcinoma. 2021; : 143 doi: 10.1007/978-981-16-2870-2_12
|
| 21 |
Moon Young Oh, Hongbeom Kim, Yoo Jin Choi, Yoonhyeong Byun, Youngmin Han, Jae Seung Kang, Heeju Sohn, Jung Min Lee, Wooil Kwon, Jin-Young Jang. Conversion surgery for initially unresectable extrahepatic biliary tract cancer. Annals of Hepato-Biliary-Pancreatic Surgery 2021; 25(3): 349 doi: 10.14701/ahbps.2021.25.3.349
|
| 22 |
Ningyu Wang, Ai Huang, Bohua Kuang, Yu Xiao, Yong Xiao, Hong Ma. Progress in Radiotherapy for Cholangiocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.868034
|
| 23 |
Divya Khosla, Samreen Zaheer, Rahul Gupta, Renu Madan, Shikha Goyal, Narendra Kumar, Rakesh Kapoor. Role of intraluminal brachytherapy in palliation of biliary obstruction in cholangiocarcinoma: A brief review. World Journal of Gastrointestinal Endoscopy 2022; 14(3): 106-112 doi: 10.4253/wjge.v14.i3.106
Abstract(384) |
Core Tip(334) |
Full Article(HTML)(1490)
|
Full Article (PDF)-733K(141)
|
Full Article (Word)-121K(78)
|
Audio-906K(5)
|
Peer-Review Report-238K(42)
|
Answering Reviewers-94K(42)
|
Times Cited (0)
|
Total Visits (4299)
|
Open
|
| 24 |
BilalO Al-Jiffry, Mohamed Al Saeed, Majed Al-Mourgi, AlaaE Younes, Samir Badr, Tamer Abdel-Rahman, Ayman Attalla, Abdullah Al-Sawat, Mohamed Hatem, Mahmoud El-Meteini, AliB Al-Jiffry. Outcome of combined complete excision of the caudate lobe with partial hepatectomy for treatment of resectable Klatskin tumors. Saudi Surgical Journal 2019; 7(2): 63 doi: 10.4103/ssj.ssj_51_18
|
| 25 |
Alessandro Rizzo, Giovanni Brandi. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Cancer Treatment and Research Communications 2021; 27: 100354 doi: 10.1016/j.ctarc.2021.100354
|
| 26 |
F.Z. Bellefkih, N. Benchakroun, I. Lalya, B. Amaoui, H. El Kacemi, A. Acharki, M. El Hfid, A. El Mazghi, T. Chekrine, Z. Bouchbika, H. Jouhadi, S. Sahraoui, N. Tawfiq, M. Michalet. Radiotherapy in the management of rare gastrointestinal cancers: A systematic review. Cancer/Radiothérapie 2023; 27(6-7): 622 doi: 10.1016/j.canrad.2023.06.010
|
| 27 |
Naohisa Kuriyama, Masanobu Usui, Kazuaki Gyoten, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Hiroyuki Kato, Yasuhiro Murata, Akihiro Tanemura, Masashi Kishiwada, Hiroyuki Sakurai, Shugo Mizuno, Shuji Isaji. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06895-1
|
| 28 |
Hossein Taghizadeh, Yawen Dong, Thomas Gruenberger, Gerald W. Prager. Perioperative and palliative systemic treatments for biliary tract cancer. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241230756
|
| 29 |
Aumkhae Sookprasert, Kosin Wirasorn, Jarin Chindaprasirt, Piyakarn Watcharenwong, Thanachai Sanlung, Siraphong Putraveephong. Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma. Recent Results in Cancer Research 2023; 219: 223 doi: 10.1007/978-3-031-35166-2_8
|
| 30 |
Jimme K. Wiggers, Bas Groot Koerkamp, David van Klaveren, Robert J. Coelen, Yung C. Nio, Peter J. Allen, Marc G. Besselink, Olivier R. Busch, Michael I. D'Angelica, Ronald P. DeMatteo, Peter T. Kingham, Thomas M. van Gulik, William R. Jarnagin. Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging. Journal of the American College of Surgeons 2018; 227(2): 238 doi: 10.1016/j.jamcollsurg.2018.03.041
|
| 31 |
Weixun Chen, Zhengnan Hu, Ganxun Li, Lei Zhang, Tao Li. The State of Systematic Therapies in Clinic for Hepatobiliary Cancers. Journal of Hepatocellular Carcinoma 2024; : 629 doi: 10.2147/JHC.S454666
|
| 32 |
Fabio Frosio, Federico Mocchegiani, Grazia Conte, Enrico Dalla Bona, Andrea Vecchi, Daniele Nicolini, Marco Vivarelli. Neoadjuvant therapy in the treatment of hilar cholangiocarcinoma: Review of the literature. World Journal of Gastrointestinal Surgery 2019; 11(6): 279-286 doi: 10.4240/wjgs.v11.i6.279
|
| 33 |
Yuta Abe, Osamu Itano, Yusuke Takemura, Takuya Minagawa, Hidenori Ojima, Masahiro Shinoda, Minoru Kitago, Hideaki Obara, Naoyuki Shigematsu, Yuko Kitagawa. Phase I study of neoadjuvant S‐1 plus cisplatin with concurrent radiation for biliary tract cancer (Tokyo Study Group for Biliary Cancer: TOSBIC02). Annals of Gastroenterological Surgery 2023; 7(5): 808 doi: 10.1002/ags3.12682
|
| 34 |
Umberto Cillo, Constantino Fondevila, Matteo Donadon, Enrico Gringeri, Federico Mocchegiani, Hans J. Schlitt, Jan N. M. Ijzermans, Marco Vivarelli, Krzysztof Zieniewicz, Steven W. M. Olde Damink, Bas Groot Koerkamp. Surgery for cholangiocarcinoma. Liver International 2019; 39(S1): 143 doi: 10.1111/liv.14089
|
| 35 |
Ali Belkouz, Lynn E. Nooijen, Hanae Riady, Lotte C. Franken, Martijn G.H. van Oijen, Cornelis J.A. Punt, Joris I. Erdmann, Heinz-Josef Klümpen. Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review. Cancer Treatment Reviews 2020; 91: 102110 doi: 10.1016/j.ctrv.2020.102110
|